Back to index
Clinilabs

Clinilabs

clinilabs.comClinical Research Organization (CRO)

What AI says about Clinilabs

Clinilabs is a full-service clinical research organization (CRO) focused exclusively on CNS drug, device, and technology development. With over 25 years of experience, they manage Phase 1-3 trials to accelerate treatments for various CNS disorders, ensuring high-quality data and compliance.

Is this your brand?

Claim this profile to keep your information accurate and add what's missing.

Not in this profile yet:

Company details

Products & Services

Phase 2-3 Trial Management

Management of Phase 2-3 clinical trials tailored for CNS drug and device development.

Clinical Research Units

Facilities and services dedicated to conducting clinical trials for CNS products.

Early Phase Development

Support for early-phase clinical trials to expedite CNS therapeutic development.

Clinical Trial Services & Technology

Comprehensive services and technology solutions for managing clinical trials in CNS.

Advisory & Regulatory CNS Expertise

Expert guidance on regulatory requirements and best practices for CNS clinical trials.

Common Questions

What types of disorders does Clinilabs focus on?

Clinilabs specializes in psychiatric, neurological, substance use, and rare CNS disorders.

How long has Clinilabs been in operation?

Clinilabs has over 25 years of global experience in clinical research.

What is the mission of Clinilabs?

Their mission is to provide high-quality, prompt, and cost-effective drug and device development services to deliver new therapeutics to those in need.

What is the significance of the Accelerator Site program?

The Accelerator Site program ensures that critical milestones in clinical trials are met on time by utilizing top-rated sites worldwide.

What technology does Clinilabs use for data management?

Clinilabs employs integrated clinical data management solutions, including eTMF, eCRF, and eSource.

Company Information

Employees
201-1000
Industries
Clinical ResearchCNS DevelopmentPharmaceuticals